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I .  Bipiperidyl mustard produced increased adiposity in the rat without excessive weight gain or hyper- 
2. The results suggest a metabolic aetiology for the obesity as opposed to a disorder of food intake 
phagia. 
regulation. 
Lesions in the ventromedial region of the hypothalamus were shown by Hetherington & 
Ranson (1940) to produce hyperphagia and obesity in the rat. The chemical agents gold 
thioglucose (GTG; Brecher & Waxler, 1949) and bipiperidyl mustard (BPM; Rutman 
et al. 1966) which are widely used to induce obesity in mice also produce lesions in this 
region of the hypothalamus (Marshall et al. 1955; Rutman et al. 1966). The use of GTG to 
induce obesity in the rat has proved to be unsuitable for widespread use and would be very 
expensive (Mayer & Marshall, 1956; Wagner & de Groot 1963). Bunyan et al. (1976) have 
shown that monosodium glutamate administered to newborn rats and mice produces 
obesity without hyperphagia. 
Miller (1979) has recently reviewed non-genetic models of obesity and has summarized 
methods which produce a high proportion of obese mice, with low mortality, using mono- 
sodium glutamate or gold thioglucose, but although he mentions the use of BPM in mice 
he does not recommend it because it is carcinogenic and difficult to obtain. He concludes 
that in all the models of obesity efficiency of energy utilization is the most important factor 
in the aetiology of the obesity. 
We now report an experiment in which obesity has been induced in the rat without mor- 
tality and inexpensively using BPM. 
MATERIALS AND METHODS 
Forty female Wistar rats weighing 170-200 g were housed in groups of five in large plastic 
cages with metal gridded floors. The animals were given FFG (M) diet (Dixon's, Ware, 
Dorset) and tap water ad lib. The animals were weighed regularly throughout the experiment 
and food intake w a s  measured with due allowance made for spillage. The animals were 
injected intraperitoneally with approximately 0.01, 0.01 5 and 0.02 mg/g body-weight of 
BPM (Aldrich Chemical Company, Wembley, Middlesex) cyclized by incubation in borate 
buffer, pH 9 (0.01 ~-borax/o.oz M-sodium chloride) at 37" for I h before injection 
(Rutman et al. 1966); control animals were injected with buffer only. The rats were killed 
by diethyl ether suffocation 12 weeks after injection and the final weights and nasoanal 
lengths were recorded. Fat content was measured by drying and Soxhlet extraction as 
previously reported (Rogers & Webb, 1980). Statistical analyses were performed using 
one-way analysis of variance, and in one instance the correlation coefficient was calculated. 
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Table I .  The initial andfinal weights (g), the weights I week after injection (g) ,  weight gains (g) ,  
nasoanal lengths (mm), fat contents (glkg)  and fat free masses ( g )  together with food intakes 
(glgroup per week) of female rats injected with various doses of cyclized bipiperidyl mustard 
(BPM) and killed 12 weeks later 
(Mean values with their standard errors for ten observations except food intakes where values are means 
of twelve weekly observations) 
Dose of BPM (mg/g body weight) 
wt (g) 
Initial 
After one week 
Final 
Total gain 
Nasoanal length (mm) 
Fat content (g/kg) 
Fat-free mass (g) 





275.1 4 8  





001 002 0.03 --- 
Mean SE Mean SE Mean SE 
187'3 2 2  184-4 32 183.8 yo 
187.4 3.6 1891 7'7 177.5 4 3  
273.9 6.1 2747 8.2 271-0 5-1 
86-6 5-4 90'9 7'0 86.2 5 1  
22 I 2 222 2 218 I 
221-6 6-5 213.3 9.0 202'0 4 8  
1192 60 1162 51 1082 66 
1-933 0.143 2'152 0136 2'538 0.157 
There was no significant effect of treatment on initial weight, final weight, weight gain. food intake or 
nasoanal length. There was a significant effect of treatment on weight I week after injection (P < OOI), 
fat content (P < 0001) and fat-free mass (P < 002) (one-way analysis of variance). 
RESULTS 
There was a highly significant (P < 0.001) effect of BPM on body fat content (g/kg) in the 
rat, at the doses used, without mortality (Table I). There was an initial period of acute 
toxicity, after injection, when treated animals lost or failed to gain weight and this was 
reflected in a significant effect of treatment on body-weight I week after injection (P < 0.01) 
with all experimental groups being lighter than the control group. Despite the increased 
final body fat content (g/kg) of the animals there was no significant effect of treatment on 
final body-weight, thus the increased fat content was at the expense of a significantly 
(P < 0.02) reduced fat-free mass. The reduced length of the treated groups approached 
but failed to reach significance (P < 0.05), although the animals of the highest dose group 
were highly significantly (P < 0.001) shorter than the controls using a Student's ' t '  test. 
A proportion of the rats in each of the treated groups had fat contents (g/kg) more than 
two standard deviations above the control mean (20% of the lowest dose, 30% of the 
middle dose and 70 yo of the highest dose). However, there was no significant increase in the 
variance of the fat contents (g/kg) of the treated groups as compared to the control group 
sbggesting that there was not a clear division of animals into responders and non-responders 
but rather that a complete shift in the distribution of fat contents (g/kg) resulted from 
treatment. This is illustrated by the observation that at the two higher doses 95 yo of the 
rats had fat contents (g/kg) above the control mean. There was a significant (P < 0.001) 
negative correlation (r - 0.59) between weight gain in the first week after injection (inversely 
related to the initial toxic effect) and the eventual fat content (g/kg). Food intake was not 
significantly affected by treatment; there was no suggestion of any persistent hyperphagia 
in treated groups. 
DISCUSSION 
It is clear that BPM is potentially a useful addition to the available models of obesity in the 
rat. Thus chemically induced obesity can be studied in the rat with the advantages this has 
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over mice in many experiments, particularly where serial bIood samples or larger volumes 
of blood are required. Obesity has been produced in a high proportion of the animals, at 
the highest dose, cheaply, without mortality and without the use of any specialized stereo- 
taxic apparatus or surgery. 
The increased adiposity without any excessive weight gain or hyperphagia but with a 
reduced fat-free mass suggests a metabolic origin for the obesity. There is a diversion of 
available energy resources from growth (i.e. increase in lean body mass) and protein 
synthesis towards fat storage and this indicates a possible hormonal imbalance in the 
aetiology. These results are strikingly similar to those reported for GTG-obesity in mice 
by Rogers et al. (1979). They reported that a proportion of outbred mice injected with gold 
thioglucose showed increased fat deposition despite having normal or reduced body-weights 
and despite the absence of any over-all hyperphagia of the treated groups during the 
experimental period. The doses of BPM chosen were based on our experience of this com- 
pound in the mouse and in retrospect it would have been useful to have extended the range 
of doses to see if the pattern of response was similar at doses nearer to the LD,. In the 
mouse (S. A. Jagot and G. P. Webb, unpublished observations) we have induced IOO % in- 
cidence of obesity and 100% overweight with doses as low as one-third of the LDW We con- 
clude that despite its reported carcinogenicity (Miller, 1979) BPM is a useful and under-used 
obesity-inducing agent which is effective in both rats and mice; we have not experienced 
difficulty in obtaining the compound. 
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